Compare MDXG & SCZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDXG | SCZM |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2007 | N/A |
| Metric | MDXG | SCZM |
|---|---|---|
| Price | $4.13 | $7.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 780.8K | 548.1K |
| Earning Date | 04-29-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.29 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $418,630,000.00 | N/A |
| Revenue This Year | N/A | $22.30 |
| Revenue Next Year | $13.14 | $69.17 |
| P/E Ratio | ★ $13.03 | $14.27 |
| Revenue Growth | ★ 19.99 | N/A |
| 52 Week Low | $4.12 | $6.90 |
| 52 Week High | $8.12 | $17.65 |
| Indicator | MDXG | SCZM |
|---|---|---|
| Relative Strength Index (RSI) | 24.51 | 25.09 |
| Support Level | N/A | N/A |
| Resistance Level | $5.38 | $12.74 |
| Average True Range (ATR) | 0.16 | 0.72 |
| MACD | -0.02 | -0.26 |
| Stochastic Oscillator | 13.29 | 3.24 |
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Santacruz Silver Mining Ltd is engaged in the operation, acquisition, exploration, and development of mineral properties in Latin America, with a primary focus on silver and zinc, including lead and copper. The company earns the majority of its revenue from Zinc and Silver. The company's reportable operating segments are the Bolivar mine and processing plant, the Porco mine and processing plant, the Caballo Blanco Group, San Lucas, Zimapan, and Corporate and Other activities. Key revenue is generated from Zimapan.